Hypoxia inhalation therapy for infants with pulmonary congestion caused by congenital heart disease.

Hypoxia inhalation therapy for infants with pulmonary congestion caused by congenital heart disease. - Hypoxia inhalation therapy for infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017311

Enrollment

Registered

2015-05-01

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoplastic left heart syndrome, coarctation of aorta, interruption of aorta, truncus arteriosus, double outlet of right ventricle (Taussig-Bing anomaly), single ventricles

Interventions

Hypoxia inhalation nitrogen inhalation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HLHS coarctation of aorta, interruption of aorta Truncus arteriosus double outlet of right ventricle single ventricles

Exclusion criteria

Exclusion criteria: without prior consent of patient's parents

Design outcomes

Primary

Measure	Time frame
blood pressure, respiratory condition, heart rate, urin output, acidemia, oxygen saturation of peripheral artery	—

Countries

Japan

Contacts

Public ContactKENTARO UENO

Kagoshima University Hospital Pediatrics

ukenta@m3.kufm.kagoshima-u.ac.jp099-275-5354

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026